1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Addition of rituximab to chemotherapy improved survival in follicular lymphoma – Healio

January 16, 2013Monoclonal Anti-CD20 Antibodiesadmin

Healio

Addition of rituximab to chemotherapy improved survival in follicular lymphoma
Healio
The addition of rituximab to chemotherapy significantly improved OS among patients with follicular lymphoma, according to results of multiple trials presented at the Myeloma & Lymphoma 2012 meeting in New York. Data from previous trials showed ...

Post navigation

← Woman is pictured holding her own heart after successful transplant Organ donor advocate honored in Rose Bowl parade – Washington Jewish Week →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos